Your technicals are pure logic. I have seen similar post of yours on PI Ind thread. This is not encouraged at valuepickr.
Posts tagged Value Pickr
Cafe Coffee Day – Will you Date? (14-10-2015)
The 17 institutional investors who bought shares a day before the IPO opened include global assets management giant Blackrock, Government Pension Fund Global, ICICI Prudential Mutual Fund, Reliance Life Insurance, Merrill Lynch, Swiss Finance Corp, Axis MF, Faering Capital India Evolving Fund, Jupiter India Fund, Platinum Asia Fund and Tarra Fund, a release from the company said
look at this,,,, Bennett, Coleman & Co. Ltd and/or its subsidiaries hold 0.80% of the equity capital of Coffee Day Enterprises Limited, as on the date of filing of the DRHP with Sebi.
Granules India Ltd (13-10-2015)
Fair argument but I don’t see any reason why Mr Market is going to pay premium of more than 30 PE for a company like Granules…. It only has an acceptable 27~ 30% growth factor going for it in 2016 & 2017.
Virat Crane Industries Limited (VCIL) – sure shot multibagger (13-10-2015)
Received this pretty informative note on the Co., from a reliable source, that I found to be quite an eye opener.
Disc: Virat forms a part of my core portfolio.
** Interesting spportunity to mall-cap olook at – Virat Crane Industries Ltd...**
Virat is a play on the largest value-added dairy products – Ghee, which accounts for 28% of the dairy industry.The dairy industry in India is highly fragmented and regional, and so is Virat. However, the industry is growing at around 13% and organized sector, which accounts for one-fourth of the industry, is growing at 20%.
Virat’s ghee, marketed under the brand “Durga”, is a 25-year old brand and a household name in Andhra Pradesh. The brand is perceived to be rich in quality, known to have a distinct aroma and flavor and is sold at a premium of 5-30% to other ghee brands in the region. It has a very strong brand recall in South India, especially Andhra Pradesh.
Over the last 3-years, higher marketing spends, geographic expansion into Karnataka and Orissa has resulted in revenue compounding at a CAGR of 36% (much higher than the industry growth of 20%) and EBITDA increase by 3.5x. This is on the back of –
Steady improvement in operating margins from 3.6% in FY12 to 13.5% in FY15, despite the increase in advertising spends from 0.2% in FY12 to 3.5% in FY15.
The robust growth in revenues was against negligible capital investments thereby leading to higher asset turns of around 13x, and healthy cash conversion cycle of 10 days. This helped the business generate healthy operating cash flows averaging at 89% of the profits over the last 3-years. ROE and ROCE also stood solid at 35% and 51%in FY15, with negligible debt on the books.
Until now Virat’s sales were “naturally” driven by the dealer network with no push from the company’s end. The management is now pursuing a three-pronged growth strategies to leverage on the premium positioning of the brand “Durga” – 1) continue to penetrate deeper into Andhra Pradesh, Orissa and Karnataka through the vast dealer network, 2) setup a new plant in Orissa to strengthen its presence in the state and also get access to new regions like West Bengal, Maharashtra and Chhattisgarh, and 3) diversify into new value-added products like curd and paneer through brand extension.
The company is hence well poised to scale its business and transform itself into a dominant value-added dairy company in Southern and Eastern part of India. Despite the healthy profitability, returns and other operating metrics, Virat trades cheap at 13x ttm earning and 8.2x EV/EBITDA, against all the other publicly traded dairy players in India.
Hitesh portfolio (13-10-2015)
Hitesh Bhai, what is your view on Marksans Pharma for long term? It’s foray in low competition niche Softgel segment looks attractive because it will help the company to survive in highly competitive regulated market like US. Strategic acquisition of Time CAP Lab will increase its front end presence in US because Products of Marksans will also be sold via Time-Cap channels. Now they are also is likely to strong their foothold in Germany , largest market in Europe by FY17. Management remains upbeat on revenue growth of 30% in coming few years. Valuation is the only major concern
GRUH Finance – mini HDFC (13-10-2015)
not much further PE expansion seems possible in Gruh – The upsides need to be funded by earnings (and earnings alone ) .
Granules India Ltd (13-10-2015)
Question : why should not market start to factor in eps as on Sep 2016 ( 1 year forward) or perhaps Mar 2017 ? Question : why should pe be capped at 30 ?
My richdreamz portfolio – visit my portfolio to learn together! (13-10-2015)
this is where one wishes if he had a higher allocation to an alpha stock
Syngene International IPO – Views invited (13-10-2015)
manish my logic is this – if 295 cuts (this is why i said “unless data proves us wrong ” )then we can see 250 (this incidentally is the issue price ) -Now my logic for 250 is simply that its the issue price so i anticipate at least temporary support there – as data is very short (just about 2 mths data since listing ) this is the only way to read it (in my view ) . Like i said if the highs are taken out then my prognosis will not hold . I base my study on oscillators and other indicators like delivery,momentum etc
Intellect Design Arena PICK for 2015 (13-10-2015)
http://www.bseindia.com/corporates/anndet_new.aspx?newsid=a27246bc-f032-470b-aedc-d17cec598e63
Some interesting news on Intellect Design. They are innovating in transaction banking platform.